Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 8, Issue 2, Pages 68-70Publisher
NATURE PORTFOLIO
DOI: 10.1038/nrclinonc.2010.224
Keywords
-
Categories
Ask authors/readers for more resources
advances in non-small-cell lung cancer over the past decade have resulted in new treatments with minimal toxic effects and dramatic clinical benefits. 2010 saw continued advancement in our understanding of the molecular genetics of lung cancer and of specific targeted inhibitors with remarkable clinical benefit in selected populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
